Cancer in the Time of Coronavirus: A Call for Crisis Oncology Standards of Care
Abstract
:1. Introduction
2. Discussion
3. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Guan, W.-J.; Ni, Z.-Y.; Hu, Y.; Liang, W.-H.; Ou, C.-Q.; He, J.-X.; Liu, L.; Shan, H.; Lei, C.-L.; Hui, D.S.; et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020, 382, 1708–1720. [Google Scholar] [CrossRef] [PubMed]
- Xia, Y.; Jin, R.; Zhao, J.; Li, W.; Shen, H. Risk of COVID-19 for cancer patients. Lancet Oncol. 2020, 21, e180. [Google Scholar] [CrossRef]
- Yeoh, C.B.; Lee, K.J.; Rieth, E.F.; Mapes, R.; Tchoudovskaia, A.V.; Fischer, G.W.; Tollinche, L.E. COVID-19 in the Cancer Patient. Anesth. Analg. 2020, 131, 16–23. [Google Scholar] [CrossRef] [PubMed]
- Dai, M.; Liu, D.; Liu, M.; Zhou, F.; Li, G.; Chen, Z.; Zhang, Z.; You, H.; Wu, M.; Zheng, Q.; et al. Patients with cancer appear more vulnerable to SARS-COV-2: A multi-center study during the COVID-19 outbreak. Cancer Discov. 2020, 10, 783–791. [Google Scholar] [CrossRef] [PubMed]
- Onder, G.; Rezza, G.; Brusaferro, S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA 2020, 323, 1775–1776. [Google Scholar] [CrossRef]
- Miyashita, H.; Mikami, T.; Chopra, N.; Yamada, T.; Chernyavsky, S.; Rizk, D.; Cruz, C. Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City. Ann. Oncol. 2020, 1–2. [Google Scholar] [CrossRef]
- Lee, L.Y.W.; Cazier, J.B.; Starkey, T.; Turnbull, C.D.; Kerr, R.; Middleton, G. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: A prospective cohort study. Lancet 2020, 395, 1919–1926. [Google Scholar] [CrossRef]
- Palmieri, C.; Palmer, D.; Openshaw, P.J.; Baille, J.K.; Semple, M.G.; Turtle, L. Cancer datasets and the SARS-CoV-2 pandemic: Establishing principles for collaboration. ESMO Open 2020, 5, e000825. [Google Scholar] [CrossRef]
- Kumar, D.; Tellier, R.; Draker, R.; Levy, G.; Humar, A. Severe Acute Respiratory Syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening. Am. J. Transpl. 2003, 3, 977–981. [Google Scholar] [CrossRef]
- Al-Jabir, A.; Kerwan, A.; Nicola, M.; Alsafi, Z.; Khan, M.; Sohrabi, C.; O’Neill, N.; Iosifidis, C.; Griffin, M.; Mathew, G.; et al. Impact of the Coronavirus (COVID-19) pandemic on surgical practice—Part 2 (surgical prioritisation). In. J. Surg. 2020, 79, 233–248. [Google Scholar] [CrossRef]
- Amit, M.; Tam, S.; Bader, T.; Sorkin, A.; Benov, A. Pausing cancer screening during the severe acute respiratory syndrome coronavirus 2pandemic: Should we revisit the recommendations? Eur. J.Cancer 2020, 134, 86–89. [Google Scholar] [CrossRef] [PubMed]
- Dinmohamed, A.G.; Visser, O.; Verhoeven, R.H.A.; Louwman, M.W.J.; Van Nederveen, F.H.; Willems, S.M.; Merkx, M.A.W.; Lemmens, V.E.P.P.; Nagtegaal, I.D.; Siesling, S. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. Lancet Oncol. 2020, 21, 750–751. [Google Scholar] [CrossRef]
- Aitken, M.; Kleinrock, M. Shifts in Healthcare Demand, Delivery, and Care During the COVID-19 Era: Tracking the Impact in the United States; IQVIA Institute for Human Data Science: Parsippany, NJ, USA, 2020. [Google Scholar]
- Sharpless, N.E. COVID-19 and cancer. Science 2020, 368, 1290. [Google Scholar] [CrossRef] [PubMed]
- Marron, J.M.; Joffe, S.; Jagsi, R.; Spence, R.A.; Hlubocky, F.J. Ethics and Resource Scarcity: ASCO Recommendations for the Oncology Community During the COVID-19 Pandemic. J. Clin. Oncol. 2020, 38, 2201–2205. [Google Scholar] [CrossRef] [PubMed]
- White, D.B. A Model Hospital Policy for Allocating Scarce Critical Care Resources. Available online: https://ccm.pitt.edu/?q=content/model-hospital-policy-allocating-scarce-critical-care-resources-available-online-now (accessed on 24 April 2020).
- Nancy, B.; Wynia, M.; Powell, T.; Hester, D.M.; Milliken, A.; Fabi, R.; Cohn, F.; Guidry-Grimes, L.K.; Watson, J.C.; Bruce, L.; et al. Ethical Framework for Health Care Institutions Responding to Novel Coronavirus SARS-CoV-2 (COVID-19) & Guidelines for Institutional Ethics Services Responding to COVID-19: Managing Uncertainty, Safeguarding Communities, Guiding Practice. Available online: https://www.thehastingscenter.org/ethicalframeworkcovid19/ (accessed on 24 April 2020).
- Hick, J.L.; Hanfling, D.; Wynia, M.K.; Pavia, A.T. Duty to Plan: Health Care, Crisis Standards of Care, and Novel Coronavirus SARS-CoV-2. NAM Perspect. 2020, 1–13. [Google Scholar] [CrossRef]
- Dietz, J.R.; Moran, M.S.; Isakoff, S.J.; Kurtzman, S.H.; Willey, S.C.; Burstein, H.J.; Bleicher, R.J.; Lyons, J.A.; Sarantou, T.; Baron, P.L.; et al. Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium. Breast Cancer Res. Treat. 2020, 181, 487–497. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ueda, M.; Martins, R.; Hendrie, P.C.; McDonnell, T.; Crews, J.R.; Wong, T.L.; McCreery, B.; Jagels, B.; Crane, A.; Byrd, D.R.; et al. Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal. J Natl. Compr. Cancer Netw. 2020, 18, 366–369. [Google Scholar] [CrossRef] [Green Version]
- Bartlett, D.L.; Howe, J.R.; Chang, G.; Crago, A.; Hogg, M.; Karakousis, G.; Levine, E.; Maker, A.; Mamounas, E.; McGuire, K.; et al. Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations. Ann. Surg. Oncol. 2020, 27, 1717–1720. [Google Scholar] [CrossRef]
- Mauri, D.; Kamposioras, K.; Tolia, M.; Alongi, F.; Tzachanis, D.; Petricevic, B.; Chilingirova, N.; Mihaylova, I.; Tsakiridis, T.; Salembier, C.; et al. Summary of international recommendations in 23 languages for patients with cancer during the COVID-19 pandemic. Lancet Oncol. 2020, 21, 759–760. [Google Scholar] [CrossRef]
- Uwins, C.; Bhandoria, G.P.; Shylasree, T.; Butler-Manuel, S.; Ellis, P.; Chatterjee, J.; Tailor, A.; Stewart, A.; Michael, A. COVID-19 and gynecological cancer: A review of the published guidelines. Int. J. Gynecol. Cancer 2020, 1–10. [Google Scholar] [CrossRef]
- Chen, H.; Wu, X.; Wang, W.; Wang, Q. When cancer encounters COVID-19 in China: What have we suffered, experienced and learned. Jpn. J. Clin. Oncol. 2020, 50, 712–717. [Google Scholar] [CrossRef] [PubMed]
- Raymond, E.; Thieblemont, C.; Alran, S.; Faivre, S. Impact of the COVID-19 Outbreak on the Management of Patients with Cancer. Target. Oncol. 2020, 15, 249–259. [Google Scholar] [CrossRef] [PubMed]
- Crisis Standards of Care: Guidance from the AMA Code of Medical Ethics. Available online: https://www.ama-assn.org/delivering-care/ethics/crisis-standards-care-guidance-ama-code-medical-ethics (accessed on 30 May 2020).
- Hantel, A.; Abel, G.A.; Siegler, M. Practical allocation system for the distribution of specialised care during cellular therapy access scarcity. J. Med. Ethics 2019, 45, 532–537. [Google Scholar] [CrossRef]
- Samik, U.; Yu, J.X.; Cristina, O.; Megan, H.; Jeffrey, H.; Hubbard-Lucey, V.M. Impact of COVID-19 on oncology clinical trials. Nat. Rev. Drug Discov. 2020, 19, 376–377. [Google Scholar] [CrossRef]
- Weinkove, R.; McQuilten, Z.K.; Adler, J.; Agar, M.R.; Blyth, E.; Cheng, A.C.; Conyers, R.; Haeusler, G.M.; Hardie, C.; Jackson, C.; et al. Managing haematology and oncology patients during the COVID -19 pandemic: Interim consensus guidance. Med. J. Aust. 2020, 212, 481–489. [Google Scholar] [CrossRef]
- Kutikov, A.; Weinberg, D.S.; Edelman, M.J.; Horwitz, E.M.; Uzzo, R.G.; Fisher, R.I. A War on Two Fronts: Cancer Care in the Time of COVID-19. Ann. Intern. Med. 2020, 172, 756–758. [Google Scholar] [CrossRef] [Green Version]
- Schrag, D.; Hershman, D.L.; Basch, E. Oncology Practice During the COVID-19 Pandemic. JAMA 2020, 323, 2005–2006. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Society | Recommendations | Links |
---|---|---|
ACR/ASBrS/NAPBC/NCCN/CoC Dietz 2020 | Joint recommendations for prioritization and treatment of patients with breast cancer. | https://www.facs.org/-/media/files/quality-programs/napbc/asbrs_napbc_coc_nccn_acr_bc_covid_consortium_recommendations.ashx |
ACS | General background on cancer and COVID-19, current advocacy efforts, common questions and answers, and patient information. | https://www.cancer.org/about-us/what-we-do/coronavirus-covid-19-and-cancer.html |
ASCO Marron 2020 | Ethical considerations for resource scarcity in cancer care. | https://www.asco.org/sites/new-www.asco.org/files/content-files/advocacy-and-policy/documents/JCO.20.00960.pdf?cid=DM4876&bid=41686163 |
ASCO | Recommendations for triage, diagnosis, treatment, infection prevention, facility management, clinical trials, and support services with links. | https://www.asco.org/sites/new-www.asco.org/files/content-files/2020-ASCO-Guide-Cancer-COVID19.pdf |
ASH | Expert recommendations on management of chemotherapy, cellular therapies, and transplant for hematologic malignancies and non-malignant diseases including thrombosis. | https://www.hematology.org/covid-19 |
ASTRO | Recommendations for screening, treatment, and follow-up of radiation therapy during the COVID-19 pandemic. | https://www.astro.org/Daily-Practice/COVID-19-Recommendations-and-Information/Summary |
EBMT | Recommendations on deferral or treatment with HSCT based on COVID-19 status of donor or recipient. | https://www.ebmt.org/sites/default/files/2020-04/EBMT-COVID-19-guidelines_v.6.1%282020-04-07%29.pdf |
ESMO | Recommendations for triage during the COVID-19 pandemic by tumor type, stage, prioritization. | https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic |
ESTRO | General recommendations on treatment and deferral with radiation therapy. | https://www.estro.org/About/Newsroom/News/Radiotherapy-in-a-time-of-crisis |
NCCN Ueda 2020 | Outline of recommendations for triage, treatment decisions, ethical considerations, and hospital management. | https://jnccn.org/view/journals/jnccn/18/4/article-p366.xml?rskey=vYDEqI&result=1 |
SIOP | Resource library, registry, and collaboration space for COVID-19 management in cancer. | https://global.stjude.org/en-us/global-covid-19-observatory-and-resource-center-for-childhood-cancer.html |
SSO Bartlett 2020 | Management of solid tumor surgeries and neoadjuvant/adjuvant chemotherapy including timing and deferral during the COVID-19 pandemic. | https://link.springer.com/article/10.1245/s10434-020-08461-2 |
WBMT | Brief recommendations regarding transplant for hematologic malignancies including potential need to delay transplants in areas with endemic or high frequency of COVID-19 infections. | https://www.wbmt.org/wp-content/uploads/2020/03/WBMT_COVID-19-2.pdf |
COSC Level | |||||
---|---|---|---|---|---|
A | B | C | D | ||
Definitions: | Chronic Care | Subacute Care | Urgent Care | Emergent Care | |
Modality | Cancer Prevention |
|
| ||
Surgery/Procedural |
|
|
|
| |
Radiation Therapy |
|
|
|
| |
Medical Oncology |
|
|
|
| |
Malignant Hematology |
|
|
|
| |
Clinical Trials |
|
|
|
| |
Cancer Survivorship |
|
|
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kelkar, A.H.; Cogle, C.R. Cancer in the Time of Coronavirus: A Call for Crisis Oncology Standards of Care. Healthcare 2020, 8, 214. https://doi.org/10.3390/healthcare8030214
Kelkar AH, Cogle CR. Cancer in the Time of Coronavirus: A Call for Crisis Oncology Standards of Care. Healthcare. 2020; 8(3):214. https://doi.org/10.3390/healthcare8030214
Chicago/Turabian StyleKelkar, Amar H., and Christopher R. Cogle. 2020. "Cancer in the Time of Coronavirus: A Call for Crisis Oncology Standards of Care" Healthcare 8, no. 3: 214. https://doi.org/10.3390/healthcare8030214